1. Home
  2. ISTR vs EBS Comparison

ISTR vs EBS Comparison

Compare ISTR & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$26.57

Market Cap

372.2M

Sector

Finance

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$8.01

Market Cap

434.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISTR
EBS
Founded
2006
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
372.2M
434.4M
IPO Year
2014
2006

Fundamental Metrics

Financial Performance
Metric
ISTR
EBS
Price
$26.57
$8.01
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$29.00
$12.00
AVG Volume (30 Days)
106.6K
983.7K
Earning Date
04-20-2026
05-06-2026
Dividend Yield
1.65%
N/A
EPS Growth
4.41
125.83
EPS
2.13
0.93
Revenue
N/A
$742,900,000.00
Revenue This Year
$66.03
$29.50
Revenue Next Year
$5.18
N/A
P/E Ratio
$12.47
$8.61
Revenue Growth
N/A
N/A
52 Week Low
$15.39
$4.02
52 Week High
$30.49
$14.06

Technical Indicators

Market Signals
Indicator
ISTR
EBS
Relative Strength Index (RSI) 34.29 30.26
Support Level $26.16 $7.66
Resistance Level $27.95 $9.47
Average True Range (ATR) 0.77 0.50
MACD -0.17 -0.02
Stochastic Oscillator 15.07 11.36

Price Performance

Historical Comparison
ISTR
EBS

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: